About Us - Precise Generics

We are IMPROVING

The effectiveness of individual treatment

About Precise Generics

At Precise Generics, we are optimizing generic drug development leveraging precision-medicine technologies to improve outcomes for oncological patients.

Our immediate goal is to provide patients and physicians with more efficient tools and, in the long run, to have a transformative impact on the cancer care system by expanding the reach of precision medicine benefits at an affordable cost.

We look to create strong partnerships with pharmaceutical firms with registered APIs or clinical-trial phase drugs on the way to getting FDA approval. Our services assist with accelerating the regulatory process and increasing the chances of success.

Cost savings for patients + financially robust industry

According to the FDA definition, “a generic drug is a medication created to be the same as an existing approved brand-name drug in dosage form, safety, strength, route of administration, quality, and performance characteristics”. For more information, visit the FDA website:

Generics drugs are usually sold at a lower cost than their brand-name counterparts. For this reason, although the United States, the UK, and Germany control the market, generics have had a substantial impact on less developed countries where people count with minimal purchasing power.

Nevertheless, Generic Medicine is a vigorous industry involving many important multinational firms, with generic drugs accounting for 90% of the U.S drug prescriptions dispensed in 2019, while only 10% were brand-name drugs.

Enablers of a better healthcare experience

Our management team consists of elite industry leaders with double-digit years of experience in the pharmaceutical field with proven success in business operations, fundraising, and drug development and manufacturing.

Previous slide

Next slide